Wenjuan Nie
No 9, Beiguan Street
Tongzhou, 101149, China
Tongzhou, 101149, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Evaluation of contezolid's cerebrospinal fluid concentration and safety in tuberculous meningitis patients.
Journal: Microbiology spectrum
Published: March 13, 2026
Increasing in vivo drug exposure levels of compound WX-081 (sudapyridine) when used in combination with clofazimine or clarithromycin.
Journal: Microbiology spectrum
Published: February 26, 2026
Extended vs. standard bedaquiline treatment for MDR/RR-TB: A 5-y multi-centre study on clinical outcomes and cardiac safety in China.
Journal: International journal of antimicrobial agents
Published: February 11, 2026
Financial Feasibility of BPaL(M) Under Pretomanid Price Scenarios - China, 2023-2024.
Journal: China CDC weekly
Published: February 10, 2026
The clinical diagnostic value of metagenomic next-generation sequencing for patients with suspected nontuberculous mycobacterial osteoarticular infection: A national multicenter clinical cohort.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 24, 2026
Diagnostic value of EBUS-TBNA for intrathoracic tuberculous lymphadenitis: a retrospective cohort analysis stratified by anti-tuberculosis treatment duration.
Journal: BMC pulmonary medicine
Published: January 15, 2026
Acquired linezolid resistance in DR-TB: genotype-phenotype discordance and molecular heterogeneity in a retrospective cohort.
Journal: BMC infectious diseases
Published: November 05, 2025
The Structure, Properties, and Clinical Utility of Contezolid for Antituberculosis: A Narrative Review.
Journal: Infectious diseases and therapy
Published: August 25, 2025
Development and Validation of a Time-Dependent Nomogram for Predicting Hematological Toxicity Risk During Linezolid Therapy in Drug-Resistant Tuberculosis.
Journal: Pharmacotherapy
Published: August 20, 2025
A novel antituberculosis agent exhibits potent clinical efficacy and good safety profile: an open-label, randomized-controlled, multicenter, phase 2a trial.
Journal: Signal transduction and targeted therapy
Published: July 03, 2025
Safety and Tolerability of Contezolid Versus Linezolid for Short-Term Treatment of Rifampicin-Resistant Pulmonary Tuberculosis: A Randomized Controlled Study.
Journal: Infection and drug resistance
Published: January 11, 2025
Metagenomic next-generation sequencing of osteoarticular tissue for the diagnosis of suspected osteoarticular tuberculosis.
Journal: Microbiology spectrum
Published: November 08, 2024
Last Updated: 09/26/2026